These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23383705)

  • 1. Managing specialty medication services through a specialty pharmacy program: the case of oral renal transplant immunosuppressant medications.
    Tschida S; Aslam S; Khan TT; Sahli B; Shrank WH; Lal LS
    J Manag Care Pharm; 2013; 19(1):26-41. PubMed ID: 23383705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a Novel Cost-Saving Pharmacy Program on Pregabalin Use and Health Care Costs.
    Martin C; Odell K; Cappelleri JC; Bancroft T; Halpern R; Sadosky A
    J Manag Care Spec Pharm; 2016 Feb; 22(2):132-44. PubMed ID: 27015252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refill-Based Medication Use Quality Measures in Kidney Transplant Recipients: Examination of Proportion of Days Covered and Medication Possession Ratio.
    Hofmeyer BA; Look KA; Hager DR
    J Manag Care Spec Pharm; 2018 Apr; 24(4):367-372. PubMed ID: 29578851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
    Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
    J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to oral oncolytics filled through an internal health-system specialty pharmacy compared with external specialty pharmacies.
    Academia EC; Mejías-De Jesús CM; Stevens JS; Jia LY; Yankama T; Patel C; Lee J
    J Manag Care Spec Pharm; 2021 Oct; 27(10):1438-1446. PubMed ID: 34595953
    [No Abstract]   [Full Text] [Related]  

  • 8. One-Year Outcomes of an Integrated Multiple Sclerosis Disease Management Program.
    Groeneweg M; Forrester SH; Arnold B; Palazzo L; Zhu W; Yoon P; Scearce T
    J Manag Care Spec Pharm; 2018 May; 24(5):458-463. PubMed ID: 29694287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications.
    Chisholm MA; Mulloy LL; Jagadeesan M; DiPiro JT
    Clin Transplant; 2001 Oct; 15(5):330-6. PubMed ID: 11678959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total cost of care of Medicare Advantage beneficiaries participating in an appointment-based model in a national pharmacy chain.
    Luder H; Lawrence J; Musich S; Friderici J; Andrade K; Reed C; Ren J; Halpern R
    J Manag Care Spec Pharm; 2024 Aug; 30(8):782-791. PubMed ID: 39088333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of rates of adherence to oral chemotherapy medications filled through an internal health-system specialty pharmacy vs external specialty pharmacies.
    McCabe CC; Barbee MS; Watson ML; Billmeyer A; Lee CE; Rupji M; Chen Z; Haumschild R; El-Rayes B
    Am J Health Syst Pharm; 2020 Jul; 77(14):1118-1127. PubMed ID: 32537656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between health system specialty pharmacy use and health care costs among national sample of Medicare Advantage beneficiaries.
    Hellems SS; Soni A; Fasching D; Smith BS; McManus DD
    J Manag Care Spec Pharm; 2022 Feb; 28(2):244-254. PubMed ID: 35098745
    [No Abstract]   [Full Text] [Related]  

  • 13. A Comparison of Pharmacy Dispensing Channel Use and Adherence to Specialty Drugs Among Medicare Part D Beneficiaries.
    Kale HP; Patel AM; Carroll NV
    J Manag Care Spec Pharm; 2018 Apr; 24(4):317-326. PubMed ID: 29578855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of a rheumatoid arthritis disease therapy management program focusing on medication adherence.
    Stockl KM; Shin JS; Lew HC; Zakharyan A; Harada AS; Solow BK; Curtis BS
    J Manag Care Pharm; 2010 Oct; 16(8):593-604. PubMed ID: 20866164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a specialty pharmacy case management service on adherence in patients receiving oral antineoplastic agents.
    Middendorff G; Elsey R; Lounsbery B; Chadwell R
    J Oncol Pharm Pract; 2018 Jul; 24(5):371-378. PubMed ID: 28509613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating E-Prescribing and Pharmacy Claims Data for Predictive Modeling: Comparing Costs and Utilization of Health Plan Members Who Fill Their Initial Medications with Those Who Do Not.
    Chang HY; Kan HJ; Shermock KM; Alexander GC; Weiner JP; Kharrazi H
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1282-1290. PubMed ID: 32996394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a patient-centered pharmacy program and intervention in a high-risk group.
    Moore JM; Shartle D; Faudskar L; Matlin OS; Brennan TA
    J Manag Care Pharm; 2013 Apr; 19(3):228-36. PubMed ID: 23537457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications.
    Axon DR; Vaffis S; Chinthammit C; Lott BE; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989
    [No Abstract]   [Full Text] [Related]  

  • 19. Adherence, Persistence, and Expenditures for High-Cost Anti-Inflammatory Drugs in Rheumatoid Arthritis: An Exploratory Study.
    Khilfeh I; Guyette E; Watkins J; Danielson D; Gross D; Yeung K
    J Manag Care Spec Pharm; 2019 Apr; 25(4):461-467. PubMed ID: 30917076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care costs in a Medicare Advantage Prescription Drug Plan population.
    Bergeson JG; Worley K; Louder A; Ward M; Graham J
    J Manag Care Pharm; 2013 Jun; 19(5):374-84. PubMed ID: 23697475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.